Table of Contents Author Guidelines Submit a Manuscript
Journal of Analytical Methods in Chemistry
Volume 2019, Article ID 8391263, 6 pages
https://doi.org/10.1155/2019/8391263
Research Article

Chemical Investigation of a Biologically Active Schinus molle L. Leaf Extract

1Department of Drug Chemistry and Technology, Sapienza University, Rome, Italy
2Department for the Innovation in Biological, Agrofood and Forestal Systems, Tuscia University, Viterbo, Italy

Correspondence should be addressed to Stefania Garzoli; ti.1amorinu@ilozrag.ainafets

Received 14 February 2019; Accepted 5 May 2019; Published 28 July 2019

Academic Editor: Eduardo Dellacassa

Copyright © 2019 Stefania Garzoli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

The pepper tree Schinus molle L. is an evergreen ornamental plant belonging to the Anacardiaceae family, native to South America and widespread throughout the world. It has biological activities and is used in folk medicine. This paper aims to contribute to a deeper knowledge of its chemical composition and biological properties. S. molle leaf extracts were obtained by sequential extraction with solvents of different polarities and subsequently tested on the HL-60 human leukaemia cell line to define a possible cytotoxic activity. Among the investigated extracts, the petroleum ether extract revealed a high cytotoxic activity, and its chemical composition was further investigated. By a silica column chromatography, eight fractions were obtained, and their compositions were determined by GC-MS analysis. Compounds and relative abundance differed widely among the fractions; sesquiterpenes resulted the main component and alcoholic sesquiterpenes the most abundant.

1. Introduction

“Pink pepper” is the common name of Schinus molle L., a plant belonging to the Anacardiaceae family, which originates in South America and nowadays distributed throughout the world [1, 2]. S. molle is a dioecious plant with a peppery smell lanceolate leaves, pendulous branches with yellowish-white flowers arranged in clusters, and coral-red fruits in the size of peppercorns [3]. Some studies investigated different parts of the plant such as leaves, mature as well as immature fruits, stems, and branches to define the molecular composition and the related biological activities [48]. S. molle leaf essential oils showed antibacterial and antifungal activities [912], and anticancer and anti-inflammatory properties were also reported [1316].

In view of the growing interest in the application of the natural products in the food and pharmaceuticals and in order to contribute for a deeper knowledge of biological properties of S. molle, we report here our findings concerning the molecules possibly involved in the cytotoxic activity.

2. Materials and Methods

2.1. Plant Collection and Extract Preparation

Fresh leaves of female S. molle (SML) plant were collected at “Angelo Rambelli” Botanical Garden (Tuscia University, Viterbo, Italy) in October 2017, out of the flowering period. The plant materials were washed with distilled water, air-dried in a shaded area for 2–4 days, and carefully hand-selected to separate the leaves, which were kept in a plastic container and frozen at −80°C for freeze-drying. After lyophilisation, the dried material was chopped and stored at 4°C until use. Dried leaves (3.5 g) were extracted using three solvents (100 mL each) of increasing polarity such as petroleum ether, diethyl ether, and acetone in a Soxhlet apparatus. After 6 extraction cycles for each solvent (SML1: petroleum ether extract; SML2: diethyl ether extract; SML3: acetone extract), the solid extracts were obtained by rotary evaporation (RV 08-VC, IKA, USA) at low pressure and 40°C of temperature.

The yield percentage from the dried extracts was calculated using the following equation:where W1 is the dry weight of the extract after evaporating the solvent and W2 is the weight of the dried leaves.

2.2. Cell Line and Culture Conditions

The human promyelocytic leukaemia cell line (HL-60) was purchased from American Type Culture Collection (ATCC). This cell line was cultured in RPMI 1640 containing 1 mmol/L L-glutamine, supplemented with 10% (v/v) fetal bovine serum (FBS) and 1% (w/v) penicillin/streptomycin, and maintained at 37°C in humidified 5% CO2 incubator. Three times a week, cells were diluted to maintain a density of 5 × 105/mL and harvested in the exponential phase of growth.

2.3. Cell Viability Assay

To analyse the cell viability, MTT assay was used. This is a colorimetric assay able to measure the reduction of 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) by mitochondrial succinate dehydrogenase. MTT enters the cells and passes into the mitochondria where it is reduced to an insoluble, coloured, formazan product. The formazan crystals inside the cells are then solubilised with an organic solvent (DMSO) and the released, solubilised reagent is measured spectrophotometrically [17]. HL-60 cells were seeded in flat-bottom 96-well plates at a density of 1 × 104 cells/well and treated with ten 2-fold dilutions (250 μg/ml–0.485 μg/ml) for 24 h. As negative control, untreated cells were added. Vinblastine (V1377, Merck, Germany) was used as positive control with eleven 2-fold dilutions (10−6 M to 10−9 M) for 24 h. For solvent control, cells were treated with 0.1% DMSO for 24 h.

Following treatment incubation time, the media was carefully aspirated and 100 μL of MTT solution (0.5 mg/mL) added to each well; after 3 h of incubation at 37°C, the formazan crystals were dissolved with 100 μL of DMSO. Plates were read by a Sunrise Tecan microplate reader, and the absorbance was measured at 595 nm. The amount of colour produced is directly proportional to the number of viable cells.

Data showed in the present paper represented the average values of three independent measurements. EC50 value (effective concentration value) was defined as the concentration of treatment at which there was 50% growth inhibition of cell proliferation.

2.4. Low-Pressure Column Chromatography

SML1 (0.296 g) was fractionated by low-pressure column chromatography (LPLC) using silica gel 60H (0.04–0.063 mm) (Macherey-Nagel, Germany) as stationary phase [18]. The silica powder was added in a beaker to the mobile phase solvents used (hexane/diethyl ether, 80/20) and stirred to obtain a pourable slurry.

The stationary phase was packed into a glass column (h = 25 cm; d = 2.5 cm). A layer of sand was placed at the top of the silica gel, and the sample was dissolved in a small amount of the initial mobile phase and gently applied to the top of the column bed. Mixtures (v/v) of hexane (HX), diethyl ether (DE), ethyl acetate (EA), and ethanol (EtOH) in increased polarity mode were used for the elution (HX/DE 80/20; HX/DE 70/30; HX/DE 65/35; HX/DE 60/40; HX/DE 50/50; HX/DE 40/60; DE 100; DE/EA 90/10; DE/EA 80/20; DE/EA 50/50; EA 100; EA/EtOH 50/50), and the mobile phase was dropped under gravity. Fractions were collected manually, and the yield percentage of each fraction was calculated considering the dry weight of fraction after evaporating the solvent and weight of SML1.

2.5. Thin-Layer Chromatography

Fractions obtained by LPLC were analysed by thin-layer chromatography (TLC) with the purpose of defining the ones with similar chromatographic profiles and to group them. Precoated TLC sheets (20 × 20 cm Alugram® Xtra SIL G/UV254 sheet plates, Macherey-Nagel, Germany) were used for TLC. Samples were spotted on the bottom of the plate (approximately 1.5 cm above edge) by a Hamilton microsyringe. Afterwards, the TLC plates were placed in a presaturated chamber with solvents mixture HX/DE (80/20) and were let to develop. The plates were removed from the chamber before the solvents mixture reached their tops and allowed to dry under the hood and the separated spots were inspected by UV lights (254 nm and 365 nm, respectively). For terpenoid compounds detection, TLC plates were sprayed with vanillin/sulphuric acid (4.0%) and the fractions with a similar chromatographic profile were combined.

2.6. GC-MS Analysis

The GC-MS analyses (two repetitions for each sample) were performed using a PerkinElmer gas chromatograph, Model Clarus 500, equipped with a polar capillary column (Restek Stabilwax fused silica) directly coupled to a mass selective detector of the same company operated in the EI mode (70 eV).

Helium was used as the carrier gas at a flow rate of 1 mL min−1. The operating conditions were as follows: injector temperature 250°C and the oven temperature program: isothermal at 60°C for 5 min, ramped to 220°C at a rate of 5°C min−1, and finally isothermal at 220°C for 15 min. The dried extract and each fraction were dissolved in 1 ml of methanol and the injection volume for all samples was 2 μL. The injector split ratio was 1 : 10. The extract constituents were identified by comparison of their linear retention indices (relative to C8–C30 aliphatic hydrocarbons, Ultrasci injected directly into GC injector under the same operating conditions reported above) with literature values and their mass spectra were compared with those from Wiley and NIST libraries. GC-FID analysis was performed under the same experimental conditions using the same column as described for the GC-MS measurements. The FID temperature was 280°C. Percentage area values were obtained electronically from the GC-FID response, without the use of an internal standard or correction factors.

2.7. Statistical Analysis

The EC50 values from three independent graphic plots of the dose-response curve were expressed as means ± standard error of the mean (SEM). Statistical analysis was performed by one-way analysis of variance (ANOVA test) using a Stat-Plus software (AnalystSoft VC 2009) with the threshold of significance set at .

3. Results and Discussion

3.1. S. molle Extract Yields and Its Antiproliferative Activity

The yields of the three extracts obtained from S. molle leaves are reported in Table 1. Petroleum ether extract (SML1) showed a yield about 8%, while the diethyl ether extract (SML2) and acetone extract (SML3) had a minor yield (1.4% and 2.0%, respectively). SML1, SML2, and SML3 were investigated by MTT assay to define the antiproliferative activities on human leukaemia cells (HL-60 cells). Each sample showed dose-dependent inhibition effects after 24 h of treatment. EC50 of the extracts exhibited values not exceeding 30.0 μg/mL. The petroleum ether extract (SML1) showed a stronger antiproliferative activity with an EC50 value of 13.3 ± 6.1 μg/mL (Table 1).

Table 1: Obtained yields and antiproliferative activities of S. molle leaf extracts (SML1, SML2, and SML3) against human leukaemia cells (HL-60) expressed by EC50 (mean values ± SEM).
3.2. LPLC Fractions

According to the results obtained by MTT assay, SML1 was fractionated by LPLC to investigate its components, and after comparison by TLC, those having a similar chromatographic profile were reunited in eight final fractions (F1–F8) whose yields are reported in Table 2.

Table 2: SML1 fractions obtained by LPLC and tested on human leukaemia cells (HL-60).
3.3. GC-MS Analyses

SML1 was analysed by GC and GC-MS analytical techniques, revealing that the extract consisted of 31 components (Table 3). The composition of the extract was dominated by sesquiterpene alcohol (56.41%), sesquiterpene hydrocarbons (25.17%), and a lower percentage of monoterpene hydrocarbons (4.18%). The major identified component from the sesquiterpenes family was elemol (46.28%) followed by germacrene D (18.10%); on the contrary, sabinene was detected as the major constituent of the terpenes group (1.65%). The presence of the squalene was relevant reaching 10.60%. Deveci et al. [19] reported germacrene D as a major constituent of S. molle leaf hexane extract. The composition of Schinus may differ by seasons, regions from which the plant material was collected, and by solvents and parts (leaves or fruits) of the plant used for the extraction [20].

Table 3: Chemical composition (%) of the petroleum ether extract (SML1) and fractions from female S. molle leaves.

The GC-MS analysis of the fractions obtained from the extract consisted of a mixture of different classes of identified compounds, which are reported as separate columns in Table 3. The main components of fraction F1 were δ-cadinene (50.58%), germacrene D (20.70%), and dehydroxy-isocalamendiol (18.45%). Fraction F2 was mainly characterised by elemene (72.16%) whereas dehydroxy-isocalamendiol (73.85%) was the most abundant in fraction F3. Fraction F4 was almost constituted by squalene (93.85%) while fraction F5 was made up of two components: β-thujene (49.88%) and β-terpinene (50.12%), present in similar percentage ratio. In fraction F6, β-thujene was the main component (67.97%) followed by sabinene (23.37%). Fraction F7 was almost entirely constituted by alloaromadendrene (95.21%) while the fraction F8 by β-eudesmol (65.87%). Other works reported the identification of high amounts of sesquiterpenes in the analysed extracts [21].

3.4. Antiproliferative Activity of LPLC Fractions

The fractions obtained by LPLC were tested by MTT and the results are reported in Table 2. Each of the eight fractions showed a relevant antiproliferative activity against human leukaemia cells with EC50 values ranging from 143.5 μg/mL to 3.8 μg/mL. Fraction F4, in which squalene represents 93.85%, was found to be the most active (EC50: 3.8 μg/mL). Squalene is a triterpene molecule able to inhibit chemically induced colon, lung, and skin tumorigenesis in rodents and is investigated as an adjuvant cancer therapy [2226].

Fractions F5 and F6, with a similar antiproliferative activity (EC50: 4.1 μg/mL; 5.4 μg/mL respectively), were mainly characterised by components belonging to the family of terpenes (β-thujene, β-terpinene, and sabinene). In particular, β-thujene from several plants and/or essential oils [27] has been described to be important for its antioxidant and antimicrobial activities.

β-Terpinene is one of three isomeric monoterpenes differing in the positions of their two double bonds (α- and γ-terpinene being the others). Terpinenes are three isomeric hydrocarbons that are classified as terpenes. Terpenes, one of the most extensive and varied structural group of compounds occurring in nature, display a wide range of biological and pharmacological activities and strong antioxidant property [28]. Wiart [29] has reported that the terpenes compromise the cell cycle in different types of malignancies by targeting the mitotic spindle and cyclins and thus triggering apoptosis.

Fractions F3 and F5 (EC50: 5.5 μg/mL; 6.5 μg/mL, respectively) are characterised by the presence of compounds belonging to the sesquiterpenes group. Dehydroxy-isocalamendiol is the main component of fraction F3 (73.85%) and is also present in fraction F1 (18.45%). This compound has been reported in essential oil from leaves and fruits of S. molle grown in Saudi Arabia [30].

In fraction F1, germacrene D was present; it is known that germacrene D has strong antimicrobial activity [31], and de Oliveira et al. [32] found some oils having anticancer effects in various cancer cell lines, with germacrene D as one of the main compounds.

4. Conclusions

In our study, the chemical composition of the petroleum ether extract (SML1) from leaves of Schinus molle L. and its eight fractions were determined by GC-MS and tested on HL-60 human leukaemia cells. The major component of the extract was elemol followed by germacrene D and squalene. The obtained fractions were abundantly rich in secondary metabolites such as monoterpenes and sesquiterpenes. The MTT results of the fractions demonstrated a relevant antiproliferative activity against human leukaemia cells. Considering both biological and chemical results, we hypothesise that the presence of compounds belonging to the family of terpenes (monoterpenes and sesquiterpenes) could be responsible for the activity against human leukaemia cells (HL-60). In the next future, the molecules here identified as possible responsible for anticancer activity could open perspectives to formulate new chemotherapeutic agents of natural origin.

Data Availability

The data used to support the findings of this study are included within the article.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Acknowledgments

This work was supported by the PRONAT Project “Selection and characterization of bioactive compounds,” Università degli Studi della Tuscia-Viterbo (Italy).

References

  1. F. L. Kramer, “The pepper tree, Schinus molle L.,” Economic Botany, vol. 11, no. 4, pp. 322–326, 1957. View at Publisher · View at Google Scholar · View at Scopus
  2. D. J. Goldstein and R. C. Coleman, “Schinus molle L. (Anacardiaceae) Chicha production in the central Andes,” Economic Botany, vol. 58, no. 4, pp. 523–529, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Kasimala and B. B. Kasimala, “A review on Brazilian pepper plant: Schinus molle,” Journal of Atoms and Molecules, vol. 2, no. 2, pp. 6–13, 2012. View at Google Scholar
  4. A. Ferrero, A. Minetti, C. Bras, and N. Zanetti, “Acute and subacute toxicity evaluation of ethanolic extract from fruits of Schinus molle in rats,” Journal of Ethnopharmacology, vol. 113, no. 3, pp. 441–447, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Hosni, M. Jemli, S. Dziri et al., “Changes in phytochemical, antimicrobial and free radical scavenging activities of the Peruvian pepper tree (Schinus molle L.) as influenced by fruit maturation,” Industrial Crops and Products, vol. 34, no. 3, pp. 1622–1628, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. M. Feuereisen, B. F. Zimmermann, N. Schulze-Kaysers, and A. Schieber, “Differentiation of Brazilian peppertree (Schinus terebinthifolius raddi) and Peruvian peppertree (Schinus molle L.) fruits by UHPLC–UV–MS analysis of their anthocyanin and biflavonoid profiles,” Journal of Agricultural and Food Chemistry, vol. 65, no. 26, pp. 5330–5338, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Yildirim, K. Ekici, and M. Çirka, “Chemical composition, antimicrobial and antioxidant properties of Schinus molle L. essential oil from Turkey,” Journal of Essential Oil Bearing Plants, vol. 20, no. 2, pp. 570–577, 2017. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Garzoli, V. Laghezza Masci, G. Turchetti, L. Pesci, A. Tiezzi, and E. Ovidi, “Chemical investigations of male and female leaf extracts from Schinus molle L.,” Natural Product Research, vol. 33, no. 13, pp. 1980–1983, 2019. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Schmourlo, R. R. Mendonça-Filho, C. S. Alviano, and S. S. Costa, “Screening of antifungal agents using ethanol precipitation and bioautography of medicinal and food plants,” Journal of Ethnopharmacology, vol. 96, no. 3, pp. 563–568, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Rhouma, H. Ben Daoud, S. Ghanmi, H. Ben Salah, M. Romdhane, and M. Demak, “Antimicrobial activities of leaf extracts of Pistacia and Schinus species against some plant pathogenic fungi and bacteria,” Journal of Plant Pathology, vol. 91, no. 2, pp. 339–345, 2009. View at Google Scholar
  11. R. Salazar-Aranda, L. A. Perez-Lopez, J. Lopez-Arroyo, B. A. Alanis-garza, and N. W. de Torres, “Antimicrobial and antioxidant activities of plants from Northeast of Mexico,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 536139, 6 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. M. D. R. Martins, S. Arantes, F. Candeias, M. T. Tinoco, and J. Cruz-Morais, “Antioxidant, antimicrobial and toxicological properties of Schinus molle L. essential oils,” Journal of Ethnopharmacology, vol. 151, no. 1, pp. 485–492, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Ruffa, G. Ferraro, M. L. Wagner, M. L. Calcagno, R. H. Campos, and L. Cavallaro, “Cytotoxic effect of argentine medicinal plant extracts on human hepatocellular carcinoma cell line,” Journal of Ethnopharmacology, vol. 79, no. 3, pp. 335–339, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Yueqin, M. C. Recio, S. Máñez, R. M. Giner, M. Cerdá-Nicolás, and J.-L. Ríos, “Isolation of two triterpenoids and a biflavanone with anti-inflammatory activity from Schinus molle fruits,” Planta Medica, vol. 69, no. 10, pp. 893–898, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Bendaoud, M. Romdhane, J. P. Souchard, S. Cazaux, and J. Bouajila, “Chemical composition and anticancer and antioxidant activities of Schinus molle L. and Schinus terebinthifolius raddi berries essential oils,” Journal of Food Science, vol. 75, no. 6, pp. C466–C472, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Kasmi, M. Hammami, M. Abderrabba, and S. Ayadi, “Schinus molle: chemical analysis, phenolic compounds and evaluation of its antioxidant activity,” Journal of Chemical and Pharmaceutical Research, vol. 8, no. 5, pp. 93–101, 2016. View at Google Scholar
  17. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983. View at Publisher · View at Google Scholar · View at Scopus
  18. R. G. Reid and S. D. Sarker, “Isolation of natural products by low-pressure column chromatography,” in Natural Products Isolation, S. D. Sarker and L. Nahar, Eds., pp. 155–187, Humana Press, Totowa, NJ, USA, 2012. View at Google Scholar
  19. O. Deveci, A. Sukan, N. Tuzun, and E. E. Hameş, “Chemical composition, repellent and antimicrobial activity of Schinus molle L.,” Journal of Medicinal Plants Research, vol. 4, no. 21, pp. 2211–2216, 2010. View at Google Scholar
  20. F. B. Carneiro, P. Q. Lopes, R. C. Ramalho, M. T. Scotti, S. G. Santos, and L. A. L. Soares, “Characterization of leaf extracts of Schinus terebinthifolius Raddi by GC-MS and chemometric analysis,” Pharmacognosy Magazine, vol. 13, no. S3, pp. S672–S675, 2017. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Lazarevic, R. Palic, N. Radulovic, N. Ristic, and G. Stojanovic, “Chemical composition and screening of the antimicrobial and anti-oxidative activity of extracts of Stachys species,” Journal of the Serbian Chemical Society, vol. 75, no. 10, pp. 1347–1359, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Rao, H. L. Newmark, and B. S. Reddy, “Chemopreventive effect of squalene on colon cancer,” Carcinogenesis, vol. 19, no. 2, pp. 287–290, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. T. J. Smith, “Squalene: potential chemopreventive agent,” Expert Opinion on Investigational Drugs, vol. 9, no. 8, pp. 1841–1848, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Murakoshi, H. Nishino, H. Tokuda et al., “Inhibition by squalene of the tumor-promoting activity of 12-O-tetradecanoylphorbol-13-acetate in mouse-skin carcinogenesis,” International Journal of Cancer, vol. 52, no. 6, pp. 950–952, 1992. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Yamaguchi, M. Nakagawa, K. Hidaxa et al., “Potentation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl) methyl]-1-(2-chloroethyl)-nitros ourea in a murine tumor system,” Japanese Journal of Cancer Research, vol. 76, no. 10, pp. 1021–1026, 1985. View at Google Scholar
  26. S. Senthilkumar, T. Devaki, B. M. Manohar, and M. S. Babu, “Effect of squalene on cyclophosphamide-induced toxicity,” Clinica Chimica Acta, vol. 364, no. 1-2, pp. 335–342, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Pengelly, The Constituents of Medicinal plants: An Introduction to the Chemistry and Therapeutics of Herbal Medicine, CABI Publishing, Wallingford, UK, 2nd edition, 2004.
  28. E. Gonzalez-Burgos and M. P. Gómez-Serranillos, “Terpene compounds in nature: a review of their potential antioxidant activity,” Current Medicinal Chemistry, vol. 19, no. 31, pp. 5319–5341, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Wiart, Lead Compounds from Medicinal Plants for the Treatment of Cancer, Academic Press, Cambridge, MA, USA, 2012.
  30. E. Abdel-Satter, A. A. Zaitoun, M. A. Farag, S. H. El Gayed, and F. M. H. Harraz, “Chemical composition, insecticidal and insect repellent activity of Schinus molle L. leaf and fruit essential oils against Trogoderma granarium and Tribolium castaneum,” Natural Product Research, vol. 24, no. 3, pp. 226–235, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Xiong, C. Peng, Q.-M. Zhou et al., “Chemical composition and antibacterial activity of essential oils from different parts of Leonurus japonicus houtt,” Molecules, vol. 18, no. 1, pp. 963–973, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. P. F. de Oliveira, J. M. Alves, J. L. Damasceno et al., “Cytotoxicity screening of essential oils in cancer cell lines,” Revista Brasileira de Farmacognosia, vol. 25, no. 2, pp. 183–188, 2015. View at Publisher · View at Google Scholar · View at Scopus